Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 874219-36-0 | MDL No. : | MFCD08061836 |
Formula : | C9H10BFO4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | YCXMTPOFCTUKTB-UHFFFAOYSA-N |
M.W : | 211.98 | Pubchem ID : | 24901771 |
Synonyms : |
|
Num. heavy atoms : | 15 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.22 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 52.31 |
TPSA : | 66.76 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.78 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 1.15 |
Log Po/w (WLOGP) : | 0.1 |
Log Po/w (MLOGP) : | 0.94 |
Log Po/w (SILICOS-IT) : | -0.07 |
Consensus Log Po/w : | 0.42 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.91 |
Solubility : | 2.6 mg/ml ; 0.0123 mol/l |
Class : | Very soluble |
Log S (Ali) : | -2.15 |
Solubility : | 1.51 mg/ml ; 0.00714 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.06 |
Solubility : | 1.86 mg/ml ; 0.00879 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.2 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Example 172 3'-Chloro-4-fluoro-4'-[3,3,3-trifluoro-2-hydroxy-1-methyl-2-(1-methyl-6-oxo-1,6-dihydro-pyridin-3-yl)-propyl]-biphenyl-3-carboxylic acid ethyl ester In analogy to Example 150, step 2, 5-[2-(4-bromo-2-chloro-phenyl)-1-hydroxy-1-trifluoromethyl-propyl]-1-methyl-1H-pyridin-2-one (Example 165, step 3) was reacted with <strong>[874219-36-0]4-fluoro-3-ethoxycarbonylphenylboronic acid</strong> to give the title compound as a colorless foam. MS (m/e)=512.4 [M+H+]. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Step 3: 3'-Chloro-4'-[2-(1-ethyl-6-oxo-1,6-dihydro-pyridin-3-yl)-3,3,3-trifluoro-2-hydroxy-1-methyl-propyl]-4-fluoro-biphenyl-3-carboxylic acid ethyl ester In analogy to Example 150, step 2, 5-[2-(4-bromo-2-chloro-phenyl)-1-hydroxy-1-trifluoromethyl-propyl]-1-ethyl-1H-pyridin-2-one was reacted with <strong>[874219-36-0]4-fluoro-3-ethoxycarbonylphenylboronic acid</strong> to give the title compound as a colorless foam. MS (m/e)=526.3 [M+H+]. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
12.3 mg | With tetrakis(triphenylphosphine) palladium(0); caesium carbonate; In tetrahydrofuran; water; at 150.0℃; for 1.0h;Inert atmosphere; Microwave irradiation; | To 78 mg (0.24 mmol) of 6-bromo-4-(difluoromethyl)-3-phenyl-1 H-pyrazolo[3,4- b]pyridine in 4 ml of a 4/1 THF/water mixture are added 92 mg (0.43 mmol) of [3- (ethoxycarbonyl)-4-fluorophenyl]boronic acid, 35 mg (0.03 mmol) of tetrakis(triphenylphosphine)palladium and 261 mg (0.8 mmol) of caesium carbonate, under an inert atmosphere of argon. The reaction medium is heated at 150°C for 60 minutes by microwave. The organic phase is separated out by settling of the phases, diluted with THF, washed with saturated aqueous sodium chloride solution and concentrated under reduced pressure. After purification by column chromatography on C- 18 reverse-phase silica gel, eluting with an acetonitrile/H2O/0.1 percent TFA mixture, 12.3 mg of a lyophilizate are obtained. MH+: 384 1H NMR (600 MHz, DMSO-d6): delta 14.31 (s, 1 H), 8.76 (dd, JA = 7.2 Hz, JB = 2.3 Hz, 1 H), 8.47 (m, 1 H), 8.04 (s, 1 H), 7.67 (d, JA = 7.9 Hz, 2 H), 7.51 (m, 4 H), 7.33 (t, JA = 54.6 Hz, 1 H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
34 mg | With tetrakis(triphenylphosphine) palladium(0); caesium carbonate; In tetrahydrofuran; water; at 150.0℃; for 1.0h;Inert atmosphere; Microwave irradiation; | To 103 mg (0.33 mmol) of 6-bromo-3-phenyl-4-(trifluoromethyl)-1 H-pyrazolo[3,4- b]pyridine in 4 ml of a 4/1 THF/water mixture are added 187 mg (0.88 mmol) of [3- (ethoxycarbonyl)-4-fluorophenyl]boronic acid, 41 mg (0.035 mmol) of tetrakis(triphenylphosphine)palladium and 293 mg (0.9 mmol) of caesium carbonate, under an inert atmosphere of argon. The reaction medium is heated at 150°C for 60 minutes by microwave. The organic phase is separated out by settling of the phases, diluted with THF, washed with saturated aqueous sodium chloride solution and concentrated under reduced pressure. The residue obtained is purified by column chromatography on C-18 reverse-phase silica gel, eluting with an acetonitrile/H2O/0.1 percent TFA mixture. The solid obtained is taken up in a 1/1 DMF/NaOH (1 N) mixture and stirred for 1 hour at room temperature. After purification by column chromatography on C-18 reverse-phase silica gel, eluting with an acetonitrile/H2O/0.1 percent TFA mixture, 34 mg of a lyophilizate are obtained. MH+: 402 1H NMR (600 MHz, DMSO-d6): delta 14.51 (s, 1 H), 13.51 (s (broad), 1 H), 8.80 (dd, JA = 7.1 Hz, JB = 2.4 Hz, 1 H), 8.51 (m, 1 H), 8.17 (s, 1 H), 7.51 (m, 6 H) |
[ 874288-38-7 ]
4-Ethoxycarbonyl-3-fluorophenylboronic acid
Similarity: 0.97
[ 874219-35-9 ]
4-Fluoro-3-methoxycarbonylphenylboronic acid
Similarity: 0.97
[ 871329-62-3 ]
3-Fluoro-5-methoxycarbonylphenylboronic Acid
Similarity: 0.89
[ 850568-04-6 ]
(2-Fluoro-5-(methoxycarbonyl)phenyl)boronic acid
Similarity: 0.88
[ 603122-84-5 ]
2-Fluoro-4-(methoxycarbonyl)phenylboronic acid
Similarity: 0.88
[ 874288-38-7 ]
4-Ethoxycarbonyl-3-fluorophenylboronic acid
Similarity: 0.97
[ 874219-35-9 ]
4-Fluoro-3-methoxycarbonylphenylboronic acid
Similarity: 0.97
[ 871329-62-3 ]
3-Fluoro-5-methoxycarbonylphenylboronic Acid
Similarity: 0.89
[ 850568-04-6 ]
(2-Fluoro-5-(methoxycarbonyl)phenyl)boronic acid
Similarity: 0.88
[ 603122-84-5 ]
2-Fluoro-4-(methoxycarbonyl)phenylboronic acid
Similarity: 0.88
[ 874288-38-7 ]
4-Ethoxycarbonyl-3-fluorophenylboronic acid
Similarity: 0.97
[ 874219-35-9 ]
4-Fluoro-3-methoxycarbonylphenylboronic acid
Similarity: 0.97
[ 871329-62-3 ]
3-Fluoro-5-methoxycarbonylphenylboronic Acid
Similarity: 0.89
[ 850568-04-6 ]
(2-Fluoro-5-(methoxycarbonyl)phenyl)boronic acid
Similarity: 0.88
[ 603122-84-5 ]
2-Fluoro-4-(methoxycarbonyl)phenylboronic acid
Similarity: 0.88
[ 874288-38-7 ]
4-Ethoxycarbonyl-3-fluorophenylboronic acid
Similarity: 0.97
[ 874219-35-9 ]
4-Fluoro-3-methoxycarbonylphenylboronic acid
Similarity: 0.97
[ 871329-62-3 ]
3-Fluoro-5-methoxycarbonylphenylboronic Acid
Similarity: 0.89
[ 850568-04-6 ]
(2-Fluoro-5-(methoxycarbonyl)phenyl)boronic acid
Similarity: 0.88
[ 603122-84-5 ]
2-Fluoro-4-(methoxycarbonyl)phenylboronic acid
Similarity: 0.88